Alpha 2.0
Login Register
» Articles » PMID: 25403223

Reply to N.-K.V. Cheung Et Al

Overview
Journal J Clin Oncol
Specialty Oncology
Date 2014 Nov 19
PMID 25403223
Citations 2
Authors
Katherine K Matthay
Wendy B London
John Maris
Peter C Adamson
Julie R Park
Affiliations
Soon will be listed here.
Citing Articles

Long-term outcomes of the GPOH NB97 trial for children with high-risk neuroblastoma comparing high-dose chemotherapy with autologous stem cell transplantation and oral chemotherapy as consolidation.

Berthold F, Ernst A, Hero B, Klingebiel T, Kremens B, Schilling F Br J Cancer. 2018; 119(3):282-290.

PMID: 29991700 PMC: 6068129. DOI: 10.1038/s41416-018-0169-8.

Tandem high-dose chemotherapy with thiotepa and busulfan-melphalan and autologous stem cell transplantation in very high-risk neuroblastoma patients.

Pasqualini C, Dufour C, Goma G, Raquin M, Lapierre V, Valteau-Couanet D Bone Marrow Transplant. 2015; 51(2):227-31.

PMID: 26524264 DOI: 10.1038/bmt.2015.264.

References
1.
Matthay K, Reynolds C, Seeger R, Shimada H, Adkins E, Haas-Kogan D . Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study. J Clin Oncol. 2009; 27(7):1007-13. PMC: 2738615. DOI: 10.1200/JCO.2007.13.8925. View
2.
Pritchard J, Cotterill S, Germond S, Imeson J, de Kraker J, Jones D . High dose melphalan in the treatment of advanced neuroblastoma: results of a randomised trial (ENSG-1) by the European Neuroblastoma Study Group. Pediatr Blood Cancer. 2004; 44(4):348-57. DOI: 10.1002/pbc.20219. View
3.
Kreissman S, Seeger R, Matthay K, London W, Sposto R, Grupp S . Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial. Lancet Oncol. 2013; 14(10):999-1008. PMC: 3963485. DOI: 10.1016/S1470-2045(13)70309-7. View
4.
Gustafson W, Matthay K . Progress towards personalized therapeutics: biologic- and risk-directed therapy for neuroblastoma. Expert Rev Neurother. 2011; 11(10):1411-23. DOI: 10.1586/ern.11.103. View
5.
Berthold F, Boos J, Burdach S, Erttmann R, Henze G, Hermann J . Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial. Lancet Oncol. 2005; 6(9):649-58. DOI: 10.1016/S1470-2045(05)70291-6. View